ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Treatment Doesn’t Always Follow Recommendations

February 25, 2005

NCI Cancer Center Support Grants Listed, 1989 vs. 1995

March 22, 1996

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995

Contracts Awarded For $30 Million Heavy Smokers Clinical Trials

October 10, 1986